The chart is not accessible to screen readers. Please switch to the table view to access the data.
Advertisement
Advertisement
Distribution of Mexican brand vs generic drug market as of 2014
Market distribution of generic and brand drugs in Mexico 2014
This statistic illustrates the distribution of generic and branded drugs in the Mexican pharmaceutical market, as of 2014. As by value, original retail brand drugs dominate the market with a ** percent share.
Log in or register to access precise data.
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Generic market share value change worldwide 2006 vs. 2016, by region
- Premium Statistic Market share of generics in Finland 2016-2021
- Premium Statistic Market share of generic drugs among OECD countries 2018
- Premium Statistic Share licensed drugs sales value local pharmaceutical Philippines 2007-2016, by type
- Premium Statistic Generics share of prescription spending in the U.S. by formulation 2012 vs. 2017
- Basic Statistic Medicare Part D coverage gap cost-sharing for brand and generic drugs 2019
- Premium Statistic Generic market share change in unit volume worldwide 2006 vs. 2016, by region
- Basic Statistic Top generic drugs in the U.S. by dispensed Rx 2023
- Premium Statistic Generic share of dispensed prescriptions by formulation U.S. 2012 vs. 2017
- Basic Statistic Total point of sale payments for brand medicines in the U.S. 2013-2020
About the region
10
- Premium Statistic Forecasted generic drug sales in Mexico 2015-2025
- Premium Statistic Pharmaceutical production volume in Mexico 2021, by segment
- Premium Statistic Main pharmacies in Mexico 2019, by size
- Basic Statistic Share of Mexican medical device exports in 2016, by product
- Premium Statistic FDI pharma production in Mexico 2010-2022
- Premium Statistic Pharma production industry salary spending in Mexico 2015-2023
- Premium Statistic Mexico: veterinary pharmaceutical laboratories 2018, by type
- Premium Statistic Pharmaceutical manufacturing establishments in Mexico 2018-2024
- Premium Statistic Mexico: usage of generic vs patented drugs 2019
- Premium Statistic Mexico: pharmaceutical expenditure 2012-2018
Selected statistics
10
- Basic Statistic Market share of generics in European countries 2024
- Premium Statistic Total savings of top generic drugs in U.S. 2015-2024
- Premium Statistic Savings through generic drug usage in the U.S., by payer 2024
- Premium Statistic Savings through generic drug usage in the U.S., by age group share 2024
- Basic Statistic Worldwide generic prescription drug sales 2012-2026
- Premium Statistic U.S. brand and generic prescription drug spending 2020-2023
- Premium Statistic Sales value of pharmaceuticals produced in Mexico 2024, by segment
- Premium Statistic Rx drugs consumption by DDD usage in Norway 2010-2024
- Premium Statistic Adamed Pharma employment value in Poland 2013-2024
- Premium Statistic Pelion employment value in Poland 2014-2024
Other regions
10
- Premium Statistic Loss of Neupogen sales to U.S. biosimilars 2015-2017
- Basic Statistic 3 year average R&D cost to develop new biopharmaceutical compounds 2010-2020
- Premium Statistic Size comparison of small-moelcule drugs and biologics 2020
- Premium Statistic Percentage return on R&D among large cap biopharma companies 2010-2020
- Basic Statistic U.S. specialists and familiarity with biosimilars 2021
- Basic Statistic Physician office payment for biosimilars in Medicare Part B 2022
- Premium Statistic Cost to bring large cap biopharmaceutical assets to market 2010-2020
- Premium Statistic Major drug manufacturers Japan FY 2020, by wholesalers' sales share
- Premium Statistic Opinion on drug spending reduction due to biosimilars for specialty drugs 2017-2020
- Premium Statistic Potential biosimilars savings in EU5 countries and the U.S. 2016-2020
Related statistics
10
- Premium Statistic Major biologics to lose patent protection 2015-2020 by EU5 and U.S. revenue
- Premium Statistic Cumulative potential biosimilars market in EU5 countries and the U.S. 2016-2020
- Premium Statistic Market share of companies in branded generic drugs Philippines 2007-2016, by type
- Premium Statistic Brand and generic prescription medication spending in the U.S. 2006-2021
- Basic Statistic Total statutory rebates and fees for brand medicines in US by component 2013-2020
- Basic Statistic R&D cost to develop new pharmaceutical compounds 2010-2020
- Premium Statistic Biosimilars approved for marketing Europe vs U.S. 2022 by year since approval
- Premium Statistic Total savings through generic drug usage in the U.S. by state 2024
- Premium Statistic Sawai Pharmaceutical's number of employees FY 2013-2022
- Premium Statistic Number of pharmaceutical products manufacturing enterprises in Poland 2020-2023
Further Content: You might find this interesting as well
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Website (mexicosalud.com). (August 21, 2015). Distribution of Mexican brand vs generic drug market as of 2014 [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 29, 2026, from /statistics/479139/generic-and-brand-drug-mexico-market-distribution/
Website (mexicosalud.com). "Distribution of Mexican brand vs generic drug market as of 2014." Chart. August 21, 2015. ÌÇÐÄÆƽâ°æ. Accessed July 29, 2026. /statistics/479139/generic-and-brand-drug-mexico-market-distribution/
Website (mexicosalud.com). (2015). Distribution of Mexican brand vs generic drug market as of 2014. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 29, 2026. /statistics/479139/generic-and-brand-drug-mexico-market-distribution/
Website (mexicosalud.com). "Distribution of Mexican Brand Vs Generic Drug Market as of 2014." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 21 Aug 2015, /statistics/479139/generic-and-brand-drug-mexico-market-distribution/
Website (mexicosalud.com), Distribution of Mexican brand vs generic drug market as of 2014 ÌÇÐÄÆƽâ°æ, /statistics/479139/generic-and-brand-drug-mexico-market-distribution/ (last visited July 29, 2026)
Distribution of Mexican brand vs generic drug market as of 2014 [Graph], Website (mexicosalud.com), August 21, 2015. [Online]. Available: /statistics/479139/generic-and-brand-drug-mexico-market-distribution/
Advertisement